stockportfolio.pro
Protagonist Therapeutics, Inc. Shares Outstanding 2014–2025
Protagonist Therapeutics, Inc. (PTGX) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 62.6M | +2.5% |
| FY 2024 | 61.0M | +5.8% |
| FY 2023 | 57.7M | +17.0% |
| FY 2022 | 49.3M | +3.1% |
| FY 2021 | 47.8M | +9.4% |
| FY 2020 | 43.7M | +60.7% |
| FY 2019 | 27.2M | +17.4% |
| FY 2018 | 23.2M | +10.0% |
| FY 2017 | 21.1M | +26.1% |
| FY 2016 | 16.7M | +6038.7% |
| FY 2015 | 0.3M | — |
| FY 2014 | 0.0M | — |
Source: Protagonist Therapeutics, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Protagonist Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeProtagonist Therapeutics, Inc. — frequently asked questions
What is Protagonist Therapeutics, Inc.'s shares outstanding?
Protagonist Therapeutics, Inc. (PTGX) reported shares outstanding of 62.6M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Protagonist Therapeutics, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.